Information
-
Trademark
-
88808590
-
Serial Number
88808590
-
Registration Number
6151953
-
International Classifications
-
Filing Date
February 24, 2020
4 years ago
-
Registration Date
September 15, 2020
4 years ago
-
Transaction Date
February 18, 2022
2 years ago
-
Status Date
September 15, 2020
4 years ago
-
Published for Opposition Date
June 30, 2020
4 years ago
-
Location Date
September 15, 2020
4 years ago
-
First Use Anywhere Date
January 01, 2019
6 years ago
-
First Use In Commerce Date
January 01, 2019
6 years ago
-
Status Code
700
-
Current Location
PUBLICATION AND ISSUE SECTION
Employee Name
KEELEY, ALISON REBECCA
-
Attorney Docket Number
45532-TM1002
Attorney Name
Aaron D. Hendelman
Law Office Assigned Location Code
M40
-
Owners
Mark Drawing Code
3000
Mark Identification
AVIDITY BIOSCIENCES
Case File Statements
- DM0000: The mark consists of the wording "AVIDITY" in an all-caps font where the "A" is formed by a down-facing angle. The wording "BIOSCIENCES" appears below in a smaller all-caps font. To the left of the wording is a highly stylized design of two curved ribbons forming a diamond or partial double-helix shape.
- CC0000: Color is not claimed as a feature of the mark.
- D10000: "BIOSCIENCES"
- GS0421: Research and development in the pharmaceutical and biotechnology fields, namely, research and development for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; research and development for the use of antibody-oligonucleotide conjugates for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; medical and scientific research services for the use of antibody-oligonucleotide conjugates for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; development of pharmaceutical preparations and medicines, namely, the development of oligonucleotide-based therapeutics
Case File Event Statements
-
2/18/2022 - 2 years ago
22 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Type: CHAN
-
2/18/2022 - 2 years ago
21 - TEAS CHANGE OF CORRESPONDENCE RECEIVED
Type: TCCA
-
2/18/2022 - 2 years ago
20 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Type: ARAA
-
2/18/2022 - 2 years ago
19 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Type: REAP
-
2/18/2022 - 2 years ago
18 - TEAS CHANGE OF OWNER ADDRESS RECEIVED
Type: COAR
-
9/15/2020 - 4 years ago
17 - REGISTERED-PRINCIPAL REGISTER
Type: R.PR
-
6/30/2020 - 4 years ago
16 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Type: NPUB
-
6/30/2020 - 4 years ago
15 - PUBLISHED FOR OPPOSITION
Type: PUBO
-
6/10/2020 - 4 years ago
14 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Type: NONP
-
5/28/2020 - 4 years ago
13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
5/28/2020 - 4 years ago
12 - APPROVED FOR PUB - PRINCIPAL REGISTER
Type: CNSA
-
5/28/2020 - 4 years ago
11 - EXAMINER'S AMENDMENT ENTERED
Type: XAEC
-
5/28/2020 - 4 years ago
10 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Type: GNEN
-
5/28/2020 - 4 years ago
9 - EXAMINERS AMENDMENT E-MAILED
Type: GNEA
-
5/28/2020 - 4 years ago
8 - EXAMINERS AMENDMENT -WRITTEN
Type: CNEA
-
5/20/2020 - 4 years ago
7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
5/20/2020 - 4 years ago
6 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
5/20/2020 - 4 years ago
5 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
5/12/2020 - 4 years ago
4 - ASSIGNED TO EXAMINER
Type: DOCK
-
2/28/2020 - 4 years ago
3 - NOTICE OF DESIGN SEARCH CODE E-MAILED
Type: MDSC
-
2/27/2020 - 4 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Type: NWOS
-
2/27/2020 - 4 years ago
1 - NEW APPLICATION ENTERED IN TRAM
Type: NWAP